Nath Bio-Genes (India) Ltd
₹150.07
(0.41%)
Wed, 11 Mar 2026, 04:30 am
Process Industries
Agricultural Commodities/Milling
24.5KNath Bio-Genes (India) Price to Sales Ratio (P/S)
| Particulars | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 6.43 | 7.40 | 9.07 | 14.53 | 23.09 | 22.84 | 5.12 | 10.24 | 0 | 7.69 | 8.33 | 7.18 |
| Price to book ratio | 0 | 0 | 1.91 | 1.76 | 1.06 | 0.78 | 1.67 | 1.73 | 0.46 | 0.93 | 0.75 | 0.47 | 0.54 | 0.43 |
| Price to sales ratio | 0 | 0 | 1.15 | 1.31 | 1.01 | 1.66 | 3.97 | 4.27 | 1.05 | 2.11 | 1.76 | 1.15 | 1.33 | 1.03 |
| Price to cash flow ratio | 0 | 0 | 14.13 | 86.56 | 0 | 0 | 0 | 0 | 61.14 | 0 | 53.85 | 9.53 | 5.02 | 25.94 |
| Enterprise value | 0 | 0 | 1.72B | 2.04B | 1.81B | 3.04B | 6.67B | 9.14B | 3.07B | 6.37B | 4.94B | 3.36B | 3.63B | 3.11B |
| Enterprise value to EBITDA ratio | 0 | 0 | 5.10 | 5.86 | 7.35 | 10.33 | 16.28 | 20.52 | 4.61 | 9.36 | 12.73 | 6.76 | 7.13 | 5.98 |
| Debt to equity ratio | 0.25 | 0.32 | 0.28 | 0.21 | 0.48 | 0.24 | 0.07 | 0.11 | 0.13 | 0.16 | 0.17 | 0.18 | 0.18 | 0.19 |
| Return on equity % | 0 | 22.76 | 34.91 | 26.89 | 12.40 | 7.67 | 9.70 | 7.87 | 9.48 | 9.51 | -11.67 | 6.28 | 6.70 | 6.15 |
Nath Bio-Genes (India) Ltd Price to Sales Ratio
The Nath Bio-Genes (India) Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Nath Bio-Genes (India) Ltd's valuation, profitability, and overall financial performance. Tracking the Nath Bio-Genes (India) Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Nath Bio-Genes (India) Ltd (NSE: NATHBIOGEN, BSE: 537291) is currently trading at ₹150.07, with a market capitalization of ₹2.85B. As a leading company in the Process industries sector and Agricultural commodities/Milling industry, monitoring the Nath Bio-Genes (India) Ltd Price to Sales Ratio is essential for fundamental analysis.
Nath Bio-Genes (India) Ltd Price to Sales Ratio Current Value
The current Nath Bio-Genes (India) Ltd Price to Sales Ratio stands at 1.03.
The Nath Bio-Genes (India) Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Nath Bio-Genes (India) Ltd Price to Sales Ratio Historical Trend
The Nath Bio-Genes (India) Ltd Price to Sales Ratio has shown the following historical trend:
- 2024: 1.03
- 2023: 1.33
- 2022: 1.15
- 2021: 1.76
- 2020: 2.11
The decline in Nath Bio-Genes (India) Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.
What Nath Bio-Genes (India) Ltd Price to Sales Ratio Indicates for Investors
The Nath Bio-Genes (India) Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.
The P/S ratio helps evaluate valuation relative to company revenue.
Nath Bio-Genes (India) Ltd Price to Sales Ratio Analysis Summary
The Nath Bio-Genes (India) Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Nath Bio-Genes (India) Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Nath Bio-Genes (India) Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800